Technology | January 25, 2012

Philips Releases Xper Flex Cardio System for Hemodynamic Monitoring

January 25, 2012 — Philips Healthcare announced the release of the Xper Flex Cardio Physiomonitoring system, a hemodynamic cardiac monitoring solution used to facilitate invasive investigation of heart and vascular disease. Equipped with advanced clinical decision support tools to assist clinicians in evaluating a patient's overall cardio performance, and general cardiovascular status, Xper Flex Cardio may also be used to display and analyze invasive blood pressure, surface electrocardiogram (ECG), respiration and other vital signs. The system is specifically designed for environments such as cath labs, EP labs and interventional radiology and cardiovascular Hybrid operating room (OR) environments.

The Xper Flex Cardio Physiomonitoring system presents several distinct advantages over previous systems, including traditional 12-lead interpretation of the resting ECG in addition to 16-lead analysis, enabling clinicians the freedom to choose which approach is most appropriate for each situation. The additional right chest and posterior leads used in 16-lead ECGs can provide information that may not be apparent on traditional 12-lead ECGs.

“Implementing Xper Flex Cardio has helped us enhance both the functionality and accuracy of our cath lab,” said Karen Keane, director, cardiac cath labs, Martin Memorial Medical Center.  “Its ability to analyze up to 16-leads of simultaneously-acquired ECG waveforms enables us to refine patient care, and its smaller size makes it the perfect system for our high-use, multi-function lab.”

Xper Flex Cardio also comes equipped with integrated fractional flow reserve (FFR) functionality—which provides data that could aid in treatment decisions, and a DXL ECG Algorithm analysis capability that uses multiple steps to produce precise and consistent ECG measurements that are used to generate interpretive statements. Additionally, the system has Culprit Artery Detection—a technology that provides suggestions on the probable site of an occlusion prior to cath procedure, saving valuable time and assisting with procedure planning—and patented ST Maps that provide a graphical indication of ST elevation.

The company also stated that it entered into an agreement with Volcano Corp, to ensure seamless experience for mutual customers of the Volcano SmartMap system.  Additionally, Philips has secured strong ties with FFR market leader St. Jude Medical.

 For more information: www.philips.com

Related Content

The Fysicon QMAPP hemodynamic monitoring system is the newest system to gain FDA clearance. It is about the size of a ream of paper.

The Fysicon QMAPP hemodynamic monitoring system is the newest system to gain FDA clearance. It is about the size of a ream of paper.

Feature | Hemodynamic Monitoring Systems | September 05, 2018 | Dave Fornell, Editor
Beyond measuring blood flow, pressure, oxygen levels and other vital signs in the cardiac catheterization lab, curren
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems | September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems | August 03, 2017 | Dave Fornell
The current generation of...
Siemens, Sensis Vibe hemodynamic system, ACC 2016
Technology | Hemodynamic Monitoring Systems | April 01, 2016
Siemens will unveil a revamped version of its established Sensis hemodynamic system at the 65 th Annual Scientific...
Feature | Hemodynamic Monitoring Systems | January 12, 2016 | Dave Fornell
Beyond measuring blood flow, pressure, oxygen levels and other vital signs in the cardiac catheterization lab, curren
Overlay Init